Session Descriptions & Learning Objectives

AzSAM Essentials of Advanced Opioid Addiction Treatment

_________________________________________
8:15 am – 9:15am
Haley Coles & Michael Dekker, DO

Overdose from all drugs, licit and illicit, continue to increase in Arizona and nationwide. By educating patients and their families on overdose prevention and naloxone use, providers have the ability to meaningfully impact overdose death, even for those who continue to use or abuse high-risk substances. This session will give lessons from provider-patient relationships, as well as from community-level interventions.

Learning Objectives:

Upon completion of this lecture participants will be able to:

  1. Effectively teach patients and other providers about overdose from all drugs, licit and illicit, continue to increase in Arizona and nationwide. By educating patients and their families on overdose prevention and naloxone use, providers have the ability to meaningfully impact overdose death, even for those who continue to use or abuse high-risk substances. This session will give lessons from provider-patient relationships, as well as from community-level interventions.

  2. Gain a framework for how to communicate overdose prevention messages from a harm reduction framework.

  3. Feel confident in ability to prescribe and/or dispense naloxone to patients and families

  4. Manage medication combinations and cessation while reducing overdose risk

  5. Conceptualize dangerous combinations of medications/substances and advice patients against these combinations.

  6. Demonstrate to patients how to effectively use naloxone products to reverse an opioid overdose, and develop more comprehensive risk reducing strategies including appropriate times to provide prescriptions for naloxone.

  7. Identify inappropriately abrupt cessation of opioids and the consequences patients face when going through acute withdrawal without assistance.

 
Special Populations:
Opioid Use Disorder in Pregnancy
9:15am – 9:45 am

Luke Peterson, DO
Discussion about screening, diagnosing, and management of opioid use disorder in pregnancy – treatment implications, fetal/neonatal effects, and the social-psycho-biologic approach.
Learning Objectives:
1. How do I screen for opioid use disorder in pregnancy?
2. How do I treat opioid use disorder in pregnancy?
3. Why should I consider long-term postpartum management of opioid use disorder?
Adolescents and Young Adults
9:45 am – 10:15 am
Tony Dekker, DO
Adolescents and Young Adults are increasing use of several chemicals after years of improvement. These include different forms of inhalation devices (e-cigarettes, vaping and JUULing), stimulants and opioids). Injection drug use has created a severe burden of illness in theLearning Objectives
1. Recognize the drugs of abuse frequently encountered by adolescents and young adults
2. Can screen adolescents for substance abuse syndrome
3. Understand the use of MAT for adolescents
Caring for Veterans who have Substance Use Disorders
10: 15 am – 10:45 am

Anita Karnik, MD
Overview of specific considerations when caring for veterans who have substance use disordersLearning Objectives:
1. Recognizing prevalent substance use disorders in the veteran population
2. Evaluating for common co-occurring psychiatric concerns that impact substance use disorders in our veteran population
3. Considerations for psychosocial factors that can impact the overall treatment plan.

Chronic Relapses, Medical Co-morbidities
11:00 am – 11:45 pm
Anthony Dekker, DO
Two topics will be covered in this discussion. Sustained recovery has been elusive for many patients burdened with substance use disorders. Opioid dependent patients who have progressed to residential treatment centers (RTCs) typically require 5 treatments and eight years to achieve one year of sobriety. MAT has shown success in maintaining engagement in treatment and continued sobriety. Medical comorbidities are 400% more likely in patients with opioid use disorders. Review of screening and treatment approaches for these common comorbidities will be covered.

Learning Objectives:
1. To monitor and empower recovering patients to maintain sobriety
2. To monitor for loss of sobriety
3. To screen for common medical problems associated with substance use disorders
4. To monitor treatment success for medical comorbidities in SUD patients.

11:45 pm – 12:15 pm
Panel Discussion / Question & Answer Session

Advanced Topics  in Buprenorphine Prescribing
1:00 pm – 2:00  pm

Mike Dekker, DO & Monica Faria, MD
The standardized Office Based Opioid Treatment course contains much information, but only covers the essentials.  This course is designed to advance the knowledge of providers using buprenorphine for the treatment of opioid use disorder.  With a focus on topics that are more complicated and now would be considered standard of care when using buprenorphine assisted treatment.  This course will greatly increase your knowledge of advanced topics when using buprenorphine.
Learning Objectives:

Upon completion of this lecture participants will be able to:

  1. Differentiate between the differing buprenorphine Formulations (Buccal/Sublinguals, Transdermal, Implants, Long Acting Injectable), and gain a concept of the usefulness of each formulation.
  2. Determine how and when the appropriate drug testing, monitoring (signs and objective evidence) is applied to patients of varying case presentations.
  3. Appropriately prepare for DEA visits to the practice and what the DEA is watching out for.
  4. Advise the patient appropriately with regards to Induction and specifically  Home Inductions: Pros and Cons.
  5. Identify appropriate switching from methadone to buprenorphine and how this can be accomplished safely.
  6. Quickly navigate to various Online templates that are pertinent to the above topics.
Chronic Pain Management and Interplay with Addiction
3:15 pm – 4:15 pm
Julian Grove, MD
We will be looking at the principles of the medications, interventions and alternative treatments related to chronic pain and how this may affect addiction issues.

Learning Objectives:

  1. Understand the basics of pain medications
  2. Understand the current legal landscape related to opioid prescribing
  3. Understand the role of opioid use disorder and the interplay of addiction issues with chronic pain patients.
Setting Up Your Practice for Optimal Success
4:15pm  – 5:15 pm
Monica Faria, MD & Simon Olstein, MD
In this session we will discuss how to determine a patient’s necessary level of care and/or intervention for treatment based on the ASAM levels of care. We will discuss how to choose the right types of therapy and/or psychosocial support for a patient with a substance use disorder. We will discuss how to recognize and address co-occurring psychiatric illnesses, with a special emphasis on suicidal risk. We will consider various practice parameters that facilitate clinical success with treating opioid use disorders, including the regular use of drug testing, informed consent, and confidentiality. We will also discuss the opportunities to recognize and address clinician bias and burnout.
Learning Objectives:
  1. How to determine the right level of care for your patient

  2. How to choose the right types of adjunct therapy for your patient

  3. Addressing co-occurring psychiatric issues

  4. Setting up your practice to aid your patient’s recovery

  5. Addressing clinician bias